The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement CentersDavid Wood, John G. Webb, Philipp Blanke et al.|JACC: Cardiovascular Interventions|2019Cited by 248
2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve ReplacementJoseph E. Bavaria, Vinod H. Thourani, Carl L. Tommaso et al.|Journal of the American College of Cardiology|2018Cited by 152
Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta‐analysisPedro Villablanca, Harish Ramakrishna, Divyanshu Mohananey et al.|Catheterization and Cardiovascular Interventions|2017Cited by 134
Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury.Robert Fishel, Bradford C. Berk, Vinod H. Thourani et al.|Journal of Clinical Investigation|1995Cited by 82
Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Comparing Transthoracic versus Transesophageal Echocardiographic GuidanceSalim S. Hayek, Stamatios Lerakis, Frank Corrigan et al.|Journal of the American Society of Echocardiography|2017Cited by 42